{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T22:03:38Z","timestamp":1780092218437,"version":"3.54.0"},"reference-count":43,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2011,9,19]],"date-time":"2011-09-19T00:00:00Z","timestamp":1316390400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Congestive Heart Failure"],"published-print":{"date-parts":[[2012,3]]},"abstract":"<jats:p>In chronic heart failure (HF), high daily doses of furosemide have been associated with increased mortality. The authors sought to evaluate the relationships between orally administered furosemide doses, clinical status, left ventricular (LV) dysfunction, N\u2010terminal proBNP (NT\u2010proBNP), and outcome in 400 outpatients with chronic HF and LV ejection fraction (EF) \u2264 45%. Clinical status, NT\u2010proBNP levels, and estimated glomerular filtration rate (eGFR) were evaluated. Median follow\u2010up duration was 32\u2003months. The median values of daily\u2010dose furosemide and of furosemide dose normalized to body surface area were 25\u2003mg (12.5\u201362.5 mg) and 15\u2003mg\/m<jats:sup>2<\/jats:sup> (13\u201334 mg\/m<jats:sup>2<\/jats:sup>), respectively. A total of 32% of patients had decompensated HF according to Framingham score and criteria for congestion. In clinically stable patients, a multivariable Cox model, which included clinical and echocardiographic parameters plus NT\u2010proBNP, hemoglobin, and eGFR, showed that normalized furosemide dose (\u200a<jats:italic>P<\/jats:italic>=.017), anemia (<jats:italic>P<\/jats:italic>=.060), age (<jats:italic>P<\/jats:italic>=.080), and New York Heart Association class (<jats:italic>P<\/jats:italic>=.080) were predictors of all cause\u2010mortality. In patients with decompensated HF, LV end\u2010systolic volume index (<jats:italic>P<\/jats:italic>=.018), NT\u2010proBNP (<jats:italic>P<\/jats:italic>=.060), and reduced eGFR (<jats:italic>P<\/jats:italic>=.070) were independently related to the outcome. Normalized furosemide dose was a major determinant of prognosis in patients with chronic HF but without ongoing signs and symptoms, and this suggests a possible negative interaction of this drug in clinically stable patients. \u00a92011 Wiley Periodicals, Inc.<\/jats:p>","DOI":"10.1111\/j.1751-7133.2011.00252.x","type":"journal-article","created":{"date-parts":[[2011,9,20]],"date-time":"2011-09-20T02:41:52Z","timestamp":1316486512000},"page":"98-106","source":"Crossref","is-referenced-by-count":17,"title":["Association of Furosemide Dose With Clinical Status, Left Ventricular Dysfunction, Natriuretic Peptides, and Outcome in Clinically Stable Patients With Chronic Systolic Heart Failure"],"prefix":"10.1111","volume":"18","author":[{"given":"Frank L.","family":"Dini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maya","family":"Guglin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anca","family":"Simioniuc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Donati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Fontanive","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Pieroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Orsini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Caravelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Marzilli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2011,9,19]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.108.821785"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0167-5273(01)00600-3"},{"key":"e_1_2_7_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2003.08.012"},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0167-5273(99)00129-1"},{"key":"e_1_2_7_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(03)00765-4"},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehi890"},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2005.12.072"},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.1067\/mhj.2002.123144"},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardfail.2008.01.015"},{"key":"e_1_2_7_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2010.05.032"},{"key":"e_1_2_7_12_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.105.584102"},{"key":"e_1_2_7_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.echo.2005.10.005"},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(99)00877-2"},{"key":"e_1_2_7_15_2","doi-asserted-by":"publisher","DOI":"10.1093\/ejechocard\/jep007"},{"key":"e_1_2_7_16_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.95.3.636"},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(97)00384-7"},{"key":"e_1_2_7_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0894-7317(14)80414-8"},{"key":"e_1_2_7_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)02060-2"},{"key":"e_1_2_7_20_2","doi-asserted-by":"publisher","DOI":"10.1067\/mhj.2000.110933"},{"key":"e_1_2_7_21_2","doi-asserted-by":"publisher","DOI":"10.1081\/JDI-120024293"},{"key":"e_1_2_7_22_2","doi-asserted-by":"publisher","DOI":"10.1159\/000180580"},{"key":"e_1_2_7_23_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11897-004-0021-8"},{"key":"e_1_2_7_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2008.08.026"},{"key":"e_1_2_7_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(02)02896-6"},{"key":"e_1_2_7_26_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.82.5.1724"},{"key":"e_1_2_7_27_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-103-1-1"},{"key":"e_1_2_7_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2010.02.039"},{"key":"e_1_2_7_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejheart.2007.05.010"},{"key":"e_1_2_7_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2008.08.080"},{"key":"e_1_2_7_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2008.05.068"},{"key":"e_1_2_7_32_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurjhf\/hfq118"},{"key":"e_1_2_7_33_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurjhf\/hfq100"},{"key":"e_1_2_7_34_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1989.03420060100040"},{"key":"e_1_2_7_35_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.109.933275"},{"key":"e_1_2_7_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2004.01.070"},{"key":"e_1_2_7_37_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000052623.16194.80"},{"key":"e_1_2_7_38_2","first-page":"154","article-title":"ACC\/AHA 2005 guideline update for the evaluation and management of chronic heart failure in the adult. A report of the American College of Cardiology\/American Heart Association task force on practice guidelines. Developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation","volume":"112","author":"Hunt S","year":"2005","journal-title":"Circulation"},{"key":"e_1_2_7_39_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurjhf\/hfq090"},{"key":"e_1_2_7_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2004.04.059"},{"key":"e_1_2_7_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2005.07.019"},{"key":"e_1_2_7_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/0009-9236(95)90222-8"},{"key":"e_1_2_7_43_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurjhf\/hfq045"},{"key":"e_1_2_7_44_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.315.7106.464"}],"container-title":["Congestive Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1751-7133.2011.00252.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1751-7133.2011.00252.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T06:16:26Z","timestamp":1698732986000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1751-7133.2011.00252.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9,19]]},"references-count":43,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["10.1111\/j.1751-7133.2011.00252.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1751-7133.2011.00252.x","archive":["Portico"],"relation":{},"ISSN":["1527-5299","1751-7133"],"issn-type":[{"value":"1527-5299","type":"print"},{"value":"1751-7133","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,9,19]]}}}